LoginSignup
profile image
B. T.
@Aktienhauptmeister
1Mon·

And Next...

12
5 Comments
profile image
Caynify@Caynify
1Mon
$HIMS will drop good numbers but the outlook will be bad after the FDA news
•
1
•
profile image
Memo0606@Memo0606
1Mon
@Caynify i hope the price will not drop
••
Chris@Multibagger
1Mon
@Caynify I think that if things go well, it will only go down to around €38-40. And that is independent of the reported figures. The share has risen massively in recent weeks without any fundamental news to justify a rise of 77% on a monthly basis. This short rally will be sold off again. The figures will only decide how far it goes in my opinion. Long-term investors should buy in 2 tranches. The first below €40 and the second below €30, so a bottom should be found at 27 at the latest.
•
1
•
Chris@Multibagger
1Mon
My first prediction was already good. We saw 38-40. Let's see if it turns now, or if we still see 27.
••
Invest2impress@Invest2impress
1Mon
All eyes on $NVDA 👀
••
Join the conversation
Sign upLogin